Inhibrx Biosciences (INBX) Receivables - Net: 2023-2025
Historic Receivables - Net for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $110,000.
- Inhibrx Biosciences' Receivables - Net fell 83.63% to $110,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $110,000, marking a year-over-year decrease of 83.63%. This contributed to the annual value of $356,000 for FY2024, which is 54.24% down from last year.
- As of Q3 2025, Inhibrx Biosciences' Receivables - Net stood at $110,000, which was down 53.59% from $237,000 recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Receivables - Net ranged from a high of $778,000 in Q4 2023 and a low of $110,000 during Q3 2025.
- Over the past 3 years, Inhibrx Biosciences' median Receivables - Net value was $271,000 (recorded in 2024), while the average stood at $376,857.
- Data for Inhibrx Biosciences' Receivables - Net shows a maximum YoY plummeted of 83.63% (in 2025) over the last 5 years.
- Inhibrx Biosciences' Receivables - Net (Quarterly) stood at $778,000 in 2023, then tumbled by 54.24% to $356,000 in 2024, then plummeted by 83.63% to $110,000 in 2025.
- Its last three reported values are $110,000 in Q3 2025, $237,000 for Q2 2025, and $214,000 during Q1 2025.